Overview

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

Status:
Completed
Trial end date:
2017-05-05
Target enrollment:
Participant gender:
Summary
The main study objective is to assess the content validity and the psychometric characteristics of the Insomnia Daytime Symptoms and Impacts Questionnaire™ (IDSIQ™).
Phase:
Phase 2
Details
Lead Sponsor:
Actelion
Idorsia Pharmaceuticals Ltd.
Treatments:
Zolpidem